← Eichor
Study identifier: NCT04889924 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

Condition: Breast Cancer · Chemotherapy · Sentinel Lymph Node  ·  Sponsor: Hospital Universitari de Bellvitge

PhaseNA
Planned participants820
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In the case of primary surgery, in patients with sentinel node involvement, it has already been shown that omitting axillary lymph node dissection (ALND), often combining axillary radiotherapy (RT), does not worsen the prognosis and does significantly reduce the appearance of lymphedema. However, patients who have received neoadjuvant systemic treatment cannot benefit from this option, even though in the majority of those who have responded well to treatment, a residual disease in the armpit is low, but there are no studies yet published that supports the possibility of not performing lymphadenectomy. The primary endpoint is to evaluate wether axillary radiotherapy (ART) presents a lower risk of lymphedema with respect to lymphadenectomy (ALND) in patients with breast cancer who, after neoadjuvant systemic treatment (NST), present the sentinel node affected. Likewise, we will evaluate recurrences and overall survival in both groups. Finally, we will analyze the quality of life of these patients.

This description comes directly from the study's public registry record.

Talk to the study team

Amparo Garcia-Tejedor, MDPhD  ·  34 + 932607695  ·  agarciat@bellvitgehospital.cat

Always discuss trial participation with your own doctor first.

Locations (60)

GenesisCare MaterSydney, New South Wales, AustraliaRecruiting
GenesisCare North ShoreSydney, New South Wales, AustraliaRecruiting
GenesisCare Frenchs ForestSydney, New South Wales, AustraliaRecruiting
GenesisCare NorwestSydney, New South Wales, AustraliaRecruiting
GenesisCare HurstvilleSydney, New South Wales, AustraliaRecruiting
GenesisCare CampbelltownSydney, New South Wales, AustraliaRecruiting
Hospital Universitari Germans Trias i PujolBadalona, Barcelona, SpainRecruiting
Instituto Catalán de Oncología de BadalonaBadalona, Barcelona, SpainRecruiting
Hospital Comarcal Sant Jaume de CalellaCalella, Barcelona, SpainRecruiting
Hospital General de GranollersGranollers, Barcelona, SpainNot Yet Recruiting
Consorci Sanitari IntegralL'Hospitalet de Llobregat, Barcelona, SpainRecruiting
Hospital Universitario de BellvitgeL'Hospitalet de Llobregat, Barcelona, SpainRecruiting

+ 48 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04889924